Clinical Outcomes of Omicron subvariants including XBB, the dominant SARS-CoV-2 in the US

The Omicron subvariant XBB.1.5 is the dominant cause of COVID-19 in the US. It is highly infectious and resistant to previous vaccinations, therapeutic monoclonal antibodies, and immunity from past infections. Being highly infectious is concerning, but does it have a high fatality rate? That is what is more important. Today, a new study was released…